Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF 10% - January 18.05.2026 FJAN.LN IE000MDKBOB3 150,002.00 USD 4,276,435.67 28.509  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Clean Edge Global Water UCITS ETF 18.05.2026 H2O LN IE000Q8F0M81 600,002.00 USD 11,714,413.55 19.524  ...

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--JM Search, the leading retained executive search firm for private equity and growth-oriented organizations, today announced that Founder and CEO John Marshall has been named a finalist for the Entrepreneur Of The Year® 2026 Greater Philadelphia program, presented by Ernst & Young LLP. The recognition honors nearly five decades of entrepreneurial leadership and Marshall's role in building JM Search into one of the nation's premier executive search firms...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - October 18.05.2026 FOCT.LN IE0004X8KUG5 100,002.00 USD 2,877,066.26 28.770  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - July 18.05.2026 FJUL.LN IE000YJBT6I5 100,002.00 USD 2,812,117.84 28.121  ...

CHARLOTTE, N.C.--(BUSINESS WIRE)--Driven Brands Holdings Inc. (NASDAQ: DRVN) (“Driven Brands” or the “Company”) today reported financial results for the fourth quarter and fiscal year ending December 27, 2025, and expects to file its 2025 Annual Report on Form 10-K with the U.S. Securities and Exchange Commission later today. The 2025 Annual Report on Form 10-K will include restated financial results for fiscal years 2024 and 2023, restated interim financial results for the periods from the fir...

PARIS--(BUSINESS WIRE)--Gustave Roussy s'associe à One Biosciences, une techbio qui exploite la technologie en cellule unique (single cell) et l'intelligence artificielle pour développer des diagnostics de précision. Cette collaboration vise à démontrer plus avant la faisabilité et l'impact d’intégrer l'analyse transcriptomique en cellule unique dans le parcours de soins des patients. Gustave Roussy, premier centre de lutte contre le cancer en Europe, s'allie à One Biosciences pour exploiter le...

PARIS--(BUSINESS WIRE)--Gustave Roussy and One Biosciences announce partnership to bring single cell to clinical practice for precision oncology....

WASHINGTON--(BUSINESS WIRE)--FiscalNote Expands PolicyNote API, Adding Local Government Intelligence to Enterprise and AI Agent Workflows...

BOSTON--(BUSINESS WIRE)--InterSystems, a creative data technology provider powering more than one billion health records globally, today announced that its electronic health record (EHR) solutions have been certified as Class IIa Medical Devices under Regulation (MDR) certification under Regulation (EU) 2017/745. This approval marks the first fully unified AI-native EHR to achieve MDR Class IIa certification in the European Union. This certification demonstrates that InterSystems AI-native EHR...